Last10K.com

Kamada Ltd (KMDA) SEC Filing 20-F Annual report for the fiscal year ending Sunday, December 31, 2017

Kamada Ltd

CIK: 1567529 Ticker: KMDA

View differences made from one year to another to evaluate Kamada Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Kamada Ltd.

Continue

Assess how Kamada Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Kamada Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Equity
Consolidated Statements Of Profit Or Loss And Other Comprehensive Income (loss)
Balances And Transactions With Related Parties
Balances And Transactions With Related Parties (narrative) (details)
Balances And Transactions With Related Parties (schedule Of Balances With Related Parties) (details)
Balances And Transactions With Related Parties (schedule Of Benefits To Key Executive Personnel) (details)
Balances And Transactions With Related Parties (schedule Of Benefits To Related Parties) (details)
Balances And Transactions With Related Parties (schedule Of Transactions With Related Parties) (details)
Balances And Transactions With Related Parties (tables)
Cash And Cash Equivalents
Cash And Cash Equivalents (narrative) (details)
Cash And Cash Equivalents (schedule Of Cash And Cash Equivalents) (details)
Cash And Cash Equivalents (tables)
Contingent Liabilities And Commitments
Contingent Liabilities And Commitments (narrative) (details)
Contingent Liabilities And Commitments (schedule Of Minimum Future Lease Fees For Existing Vehicles) (details)
Contingent Liabilities And Commitments (schedule Of Minimum Future Lease Fees For Office And Storage Spaces) (details)
Contingent Liabilities And Commitments (tables)
Disclosure Of New Ifrs In The Period
Disclusure Of New Ifrs In The Period (details)
Employee Benefit Liabilities, Net
Employee Benefit Liabilities, Net (narrative) (details)
Employee Benefit Liabilities, Net (schedule Of Changes In Fair Value Of Plan Assets) (details)
Employee Benefit Liabilities, Net (schedule Of Changes In Present Value Of Defined Benefit Obligation) (details)
Employee Benefit Liabilities, Net (schedule Of Expenses Are Presented In Statement Of Comprehensive Income (loss)) (details)
Employee Benefit Liabilities, Net (schedule Of Expenses Recognized In Comprehensive Income (loss)) (details)
Employee Benefit Liabilities, Net (schedule Of Plan Assets (liabilities), Net) (details)
Employee Benefit Liabilities, Net (schedule Of Principal Assumptions Underlying Defined Benefit Plan) (details)
Employee Benefit Liabilities, Net (tables)
Equity
Equity (narrative) (details)
Equity (schedule Of Share Capital) (details)
Equity (tables)
Financial Instruments
Financial Instruments (narrative) (details)
Financial Instruments (schedule Of Carrying Amount And Fair Value Of Financial Instruments) (details)
Financial Instruments (schedule Of Changes In Liabilities Arising From Financing Activities) (details)
Financial Instruments (schedule Of Classification Of Financial Assets And Liabilities) (details)
Financial Instruments (schedule Of Classification Of Financial Instruments By Fair Value Hierarchy) (details)
Financial Instruments (schedule Of Financial Liabilities Based On Contractual Undiscounted Payments) (details)
Financial Instruments (schedule Of Linkage Terms Of Financial Liabilities By Groups Of Financial Instruments) (details)
Financial Instruments (schedule Of Sensitivity Test) (details)
Financial Instruments (tables)
General
Guarantees And Charges
Guarantees And Charges (details)
Income (loss) Per Share
Income (loss) Per Share (schedule Of Details Of Number Of Shares And Income (loss)) (details)
Income (loss) Per Share (tables)
Inventories
Inventories (narrative) (details)
Inventories (schedule Of Inventories) (details)
Inventories (tables)
Loans And Capital Leases
Loans And Capital Leases (narrative) (details)
Loans And Capital Leases (schedule Of Loans And Capital Leases) (details)
Loans And Capital Leases (tables)
Operating Segments
Operating Segments (schedule Of Reporting On Operating Segments) (details)
Operating Segments (tables)
Other Accounts Payables
Other Accounts Payables (schedule Of Other Accounts Payables) (details)
Other Accounts Payables (tables)
Other Accounts Receivables
Other Accounts Receivables (schedule Of Other Accounts Receivables) (details)
Other Accounts Receivables (tables)
Other Long Term Assets
Other Long Term Assets (schedule Of Other Long Term Assets) (details)
Other Long Term Assets (tables)
Property, Plant And Equipment
Property, Plant And Equipment (narrative) (details)
Property, Plant And Equipment (schedule Of Capitalized Leasing Rights Of Land From Israel Land Administration) (details)
Property, Plant And Equipment (schedule Of Composition And Movement Of Property, Plant And Equipment) (details)
Property, Plant And Equipment (tables)
Share-based Payment
Share-based Payment (narrative) (details)
Share-based Payment (schedule Of Change Of Awards) (details)
Share-based Payment (schedule Of Expense Recognized In Financial Statements) (details)
Share-based Payment (schedule Of Inputs To Binomial Model Used For Fair Value Measurement) (details)
Share-based Payment (schedule Of Number Of Rss And Modification In Employee Rss) (details)
Share-based Payment (tables)
Short-term Investments
Short-term Investments (narrative) (details)
Short-term Investments (schedule Of Short-term Investments) (details)
Short-term Investments (tables)
Significant Accounting Judgments, Estimates And Assumptions Used In The Preparation Of The Financial Statements
Significant Accounting Policies
Significant Accounting Policies (narrative) (details)
Significant Accounting Policies (policies)
Significant Accounting Policies (schedule Of Useful Lives For Property, Plant And Equipment) (details)
Significant Accounting Policies (tables)
Supplementary Information To The Statements Of Profit And Loss
Supplementary Information To The Statements Of Profit And Loss (schedule Of Additional Information About Revenues) (details)
Supplementary Information To The Statements Of Profit And Loss (schedule Of Income And Expenses) (details)
Supplementary Information To The Statements Of Profit And Loss (schedule Of Revenues Based Of Customers) (details)
Supplementary Information To The Statements Of Profit And Loss (tables)
Taxes On Income
Taxes On Income (narrative) (details)
Taxes On Income (schedule Of Current Taxes On Income) (details)
Taxes On Income (schedule Of Weighted Combination Of Applicable Rates) (details)
Taxes On Income (tables)
Trade Payables
Trade Payables (schedule Of Trade Payables) (details)
Trade Payables (tables)
Trade Receivables, Net
Trade Receivables, Net (schedule Of Allowance For Doubtful Accounts) (details)
Trade Receivables, Net (schedule Of Analysis Of Past Due But Not Impaired Trade Receivables) (details)
Trade Receivables, Net (schedule Of Trade Receivables, Net) (details)
Trade Receivables, Net (tables)
Ticker: KMDA
CIK: 1567529
Form Type: 20-F Annual Report
Accession Number: 0001178913-18-000767
Submitted to the SEC: Tue Mar 06 2018 9:24:39 AM EST
Accepted by the SEC: Tue Mar 06 2018
Period: Sunday, December 31, 2017
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/kmda/0001178913-18-000767.htm